OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product
OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico
Cytovia driving CAR NK manufacturing to Puerto Rico
Biosimilar Solutions, Inc. enters License and Development Agreement with Reliance Life Sciences Ltd
Invest Puerto Rico elevates the Island's role as a global bioscience R&D and manufacturing hub attracting two major life-critical investments, $228M in new activity
BioSimilar Corporate Overview
Corona Virus - Real World Experience Directly from Front Lines
Regulatory Convergence -2020 Perspective
Top 10 Takeaways to New about New Biosimilar Interchangeability Guidance
Biosimilar Action Plan Long Way to Go
Game Changer - FDA Biosimilar Action Plan
Clinical Lessons Learn - Biosimilar Programs
Analytical Similarity Gaps and Lessons Learned
Early Considerations for Global Biosimilar Application - Part 1 of 3

